e-learning
resources
Amsterdam 2015
Saturday, 26.09.2015
PG14 Antibiotic stewardship for respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
MDR pathogens: definitions, mechanisms and risk factors
Eva Polverino (Barcelona, Spain)
Source:
International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections
Session:
PG14 Antibiotic stewardship for respiratory infections
Session type:
Postgraduate Course
Number:
169
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Eva Polverino (Barcelona, Spain). MDR pathogens: definitions, mechanisms and risk factors. International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
HIV and multidrug-resistant tuberculosis: overlapping risk factors
Source: Eur Respir J 2015; 45: 567-569
Year: 2015
The risk of ineffective MDR/XDR TB treatment, based on bedaquilin: factors and their influence
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation
Source: Eur Respir J 2011; 38: 749-751
Year: 2011
Risk factors for infections with potentially resistant pathogens in patients in a pneumological intensive-care-unit
Source: Eur Respir J 2002; 20: Suppl. 38, 476s
Year: 2002
Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms
Source: Eur Respir J 2007; 29: 793-803
Year: 2007
Ventilator-associated pneumonia: risk factors for antimicrobial-resistant causative pathogens
Source: Eur Respir J 2006; 28: Suppl. 50, 785s
Year: 2006
Attempt to estimate risk factors for drug resistance (DR) in tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 653s
Year: 2005
Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
TB failures, risk factors and therapeutical results
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003
Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate
Source: Eur Respir J 2010; 35: 768-775
Year: 2010
Risk factors for radiological and functional sequelae in multi-drug resistant tuberculosis
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021
MDR pathogens in the ICU: the magnitude of the problem
Source: International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia
Year: 2014
Outcome of multidrug resistant tuberculosis (MDR-TB) treatment with possible influencing factors
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia?
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
Is health care-associated pneumonia itself a predisposing factor for multi-drug resistant organisms?
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Risk factors for development of asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=57
Year: 2003
The problem of multi-drug resistant (MDR)-TB
Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties
Year: 2005
Known and emerging risk factors for asthma development: is prevention possible?
Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient
Year: 2015
Novel strategy to identify genetic risk factors for COPD severity: genetically isolated populations
Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD
Year: 2008
Definition and risk factors
Source: International Congress 2017 – Latest GOLD update
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept